Therefore, the outcomes of the present investigation provided clinical evidence that lncRNA‐MEG3 is an unfavorable prognostic factor for diabetes in acute stroke populations and revealed a novel therapeutic pathway for protection against diabetic CIRI by inhibiting lncRNA‐MEG3 through the Anxa2‐Akt regulatory axis. Here, MEG3 is linked to diabetes mellitus.